Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(33 sites)
United States
Clincial Research Site 21, Tucson, Arizona Clincial Research Site 43C, Castro Valley, California Clincial Research Site 14, Fresno, California Clincial Research Site 11, Los Angeles, California Clincial Research Site 43A, San Francisco, California Clincial Research Site 43B, San Francisco, California Clincial Research Site 54, Vista, California Clincial Research Site 47, Deerfield Beach, Florida Clincial Research Site 38, Hollywood, Florida Clincial Research Site 40, Jacksonville, Florida Clincial Research Site 19, Miami, Florida Clincial Research Site 26, Miami, Florida Clincial Research Site 13, Pembrook Pines, Florida Clincial Research Site 51, Tamarac, Florida Clincial Research Site 22, Chicago, Illinois Clincial Research Site 34, Chicago, Illinois Clincial Research Site 10, O'Fallon, Illinois Clincial Research Site 49, Springfield, Illinois Clincial Research Site 04, Bossier City, Louisiana Clincial Research Site 01, Lafayette, Louisiana Clincial Research Site 07, D'Iberville, Mississippi Clincial Research Site 02, McComb, Mississippi Clincial Research Site 30, New York, New York Clincial Research Site 37, Syosset, New York Clincial Research Site 55, Winston-Salem, North Carolina Clincial Research Site 45, Grove City, Ohio Clincial Research Site 23, Mentor, Ohio Clincial Research Site 28, Tulsa, Oklahoma Clincial Research Site 36, Philadelphia, Pennsylvania Clincial Research Site 24, Fort Worth, Texas Clincial Research Site 32, Houston, Texas Clincial Research Site 46, San Antonio, Texas Clincial Research Site 18, Suffolk, Virginia